🇺🇸 OROS hydromorphone HCl in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Myeloid Leukaemia — 1 report (10%)
  2. Azotaemia — 1 report (10%)
  3. Blood Glucose Decreased — 1 report (10%)
  4. Cardiac Failure — 1 report (10%)
  5. Cardiomyopathy — 1 report (10%)
  6. Colonic Polyp — 1 report (10%)
  7. Diarrhoea — 1 report (10%)
  8. Disease Progression — 1 report (10%)
  9. Drug Exposure During Pregnancy — 1 report (10%)
  10. Drug Withdrawal Syndrome Neonatal — 1 report (10%)

Source database →

Other Pain Management approved in United States

Frequently asked questions

Is OROS hydromorphone HCl approved in United States?

OROS hydromorphone HCl does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for OROS hydromorphone HCl in United States?

Janssen-Cilag International NV is the originator. The local marketing authorisation holder may differ — check the official source linked above.